MedPath

A Study to Evaluate The Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.

Phase 2
Conditions
Health Condition 1: E784- Other hyperlipidemia
Registration Number
CTRI/2021/07/034572
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient of age group 20 to 50 years,irrespective of their gender, religion.

2.Patients with abnormal Sr. lipid levels are singly, or in the cluster of two or all three.

3.Irrespective of taking lipid lowering drug therapy.

4.Irrespective of family hidtory of Atherosclerotic Cardiovascular Disease (ASCVD), Dyslipidaemia.

5.Patient irrespective of known case of HTN.

Exclusion Criteria

1.Patient with Mrudu koshta.

2.Patient known case of Diabetes Mellitus.

3.pregnant Woman.

4.Patient with known case of Atherosclerotic Cardiovascular Disease/ ischemic heart disease.

5.Patient with operated for heart blockages like PTCA or Bypass surgery.

6. Patient with known congenital heart disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinical study to evaluate efficacy of Draksha (vitis vinifera Lin.) Panak in Dyslipidaemia. Parameter of efficacy will be Blood Lipid Profile Reports before and after treatment.Timepoint: The drug will be given for 60 days. Patient will be assessed on 25th day, 30th day, 45th day and 60th day of the treatment.Total duration of the study will be 2 months
Secondary Outcome Measures
NameTimeMethod
A clinical study to evaluate efficacy of Draksha (vitis vinifera Lin.) Panak in Dyslipidaemia. Parameter of efficacy will be Blood Lipid Profile Reports before and after treatment. therefore secondary outcome will relief in sign and symptoms of dyslipidaemiaTimepoint: The drug will be given for 60 days. Patient will be assessed on 25th day, 30th day, 45th day and 60th day of the treatment.Total duration of the study will be 2 months
© Copyright 2025. All Rights Reserved by MedPath